Drugs.com - Pharma Industry News

GLP-1 Receptor Agonist Exposure Linked to Neovascular AMD in Patients With Diabetes

FRIDAY, June 6, 2025 -- For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with an increased risk for incident neovascular age-related macular degeneration (nAMD) development, according to a...

Jun 6, 2025 - 20:15
 0
GLP-1 Receptor Agonist Exposure Linked to Neovascular AMD in Patients With Diabetes
FRIDAY, June 6, 2025 -- For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with an increased risk for incident neovascular age-related macular degeneration (nAMD) development, according to a...
Read More

Tags:

Previous Article

The Fragrance Foundation unveils its 2025 Awards in New York

Next Article

Caregiver Concern Can Be Key to Identifying Critical Illness in Hospitalized Chi...

Related Posts

Preinjury Mobility Predicts Adults' Recovery After Lower-Extremity Fracture

Preinjury Mobility Predicts Adults' Recovery After Lowe...

May 15, 2025  0

Stereotactic Body Radiotherapy Feasible After Radical Prostatectomy

Stereotactic Body Radiotherapy Feasible After Radical P...

May 20, 2025  0

ASCO: Vepdegestrant Ups Survival in ER+, HER2− Advanced Breast Cancer With ESR1 Mutations

ASCO: Vepdegestrant Ups Survival in ER+, HER2− Advanced...

Jun 2, 2025  0